179 related articles for article (PubMed ID: 34989284)
41. Efficacy and prognosis of fertility-preserved hysteroscopic surgery combined with progesterone in the treatment of complex endometrial hyperplasia and early endometrial carcinoma.
Xu Z; Tian Y; Fu J; Xu J; Bao D; Wang G
J BUON; 2020; 25(3):1525-1533. PubMed ID: 32862600
[TBL] [Abstract][Full Text] [Related]
42. Comparison of diagnostic accuracy between endometrial curettage and pipelle aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group Study (KGOG 2019).
Kim MK; Seong SJ; Lee TS; Ki KD; Lim MC; Kim YH; Kim K; Joo WD
Jpn J Clin Oncol; 2015 Oct; 45(10):980-2. PubMed ID: 26206899
[TBL] [Abstract][Full Text] [Related]
43. [Fertility-sparing management of endometrial cancer and atypical hyperplasia].
Gonthier C; Trefoux-Bourdet A; Luton D; Koskas M
Gynecol Obstet Fertil Senol; 2017 Feb; 45(2):112-118. PubMed ID: 28368791
[TBL] [Abstract][Full Text] [Related]
44. Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: How Important Are Intrauterine Adhesions?
Mandato VD; Palomba S; Nucera GS; La Sala GB
J Minim Invasive Gynecol; 2016; 23(3):453-4. PubMed ID: 26724716
[No Abstract] [Full Text] [Related]
45. Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: How Important Are Intrauterine Adhesions?
Shokeir T
J Minim Invasive Gynecol; 2015; 22(7):1318. PubMed ID: 26205575
[No Abstract] [Full Text] [Related]
46. Conservative management of endometrial cancer: a survey amongst European clinicians.
La Russa M; Zapardiel I; Halaska MJ; Zalewski K; Laky R; Dursun P; Lindquist D; Sukhin V; Polterauer S; Biliatis I
Arch Gynecol Obstet; 2018 Aug; 298(2):373-380. PubMed ID: 29943129
[TBL] [Abstract][Full Text] [Related]
47. Reply to "Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: How Important Are Intrauterine Adhesions?".
De Marzi P; Bergamini A; Luchini S; Petrone M; Taccagni G; Mangili G; Colombo G; Candiani M
J Minim Invasive Gynecol; 2016; 23(3):454-5. PubMed ID: 26724717
[No Abstract] [Full Text] [Related]
48. Reply to "Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: How Important are Intrauterine Adhesions?".
De Marzi P; Bergamini A; Luchini S; Petrone M; Taccagni G; Mangili G; Colombo G; Candiani M
J Minim Invasive Gynecol; 2015; 22(7):1319. PubMed ID: 26205576
[No Abstract] [Full Text] [Related]
49. A comparison of the effect of levonorgestrel IUD with oral medroxyprogesterone acetate on abnormal uterine bleeding with simple endometrial hyperplasia and fertility preservation.
Karimi-Zarchi M; Dehghani-Firoozabadi R; Tabatabaie A; Dehghani-Firoozabadi Z; Teimoori S; Chiti Z; Miratashi-Yazdi A; Dehghani A
Clin Exp Obstet Gynecol; 2013; 40(3):421-4. PubMed ID: 24283179
[TBL] [Abstract][Full Text] [Related]
50. [GnRH-a combined fertility-sparing re-treatment in women with endometrial carcinoma or atypical endomertial hyperplasia who failed to oral progestin therapy].
Chen JY; Cao DY; Zhou HM; Yu M; Yang JX; Wang JH; Zhang Y; Cheng NH; Peng P
Zhonghua Fu Chan Ke Za Zhi; 2021 Aug; 56(8):561-568. PubMed ID: 34420288
[No Abstract] [Full Text] [Related]
51. Metformin plus megestrol acetate compared with megestrol acetate alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomised controlled trial.
Yang BY; Gulinazi Y; Du Y; Ning CC; Cheng YL; Shan WW; Luo XZ; Zhang HW; Zhu Q; Ma FH; Liu J; Sun L; Yu M; Guan J; Chen XJ
BJOG; 2020 Jun; 127(7):848-857. PubMed ID: 31961463
[TBL] [Abstract][Full Text] [Related]
52. Six months response rate of combined oral medroxyprogesterone/levonorgestrel-intrauterine system for early-stage endometrial cancer in young women: a Korean Gynecologic-Oncology Group Study.
Kim MK; Seong SJ; Kang SB; Bae DS; Kim JW; Nam JH; Lim MC; Lee TS; Kim S; Paek J
J Gynecol Oncol; 2019 Mar; 30(2):e47. PubMed ID: 30740964
[TBL] [Abstract][Full Text] [Related]
53. Prognostic impact of hysteroscopic resection of endometrial atypical hyperplasia-endometrioid intraepithelial neoplasia and early-stage cancer in combination with megestrol acetate.
Masciullo V; Trivellizzi N; Zannoni G; Catena U; Moroni R; Fanfani F; Scambia G
Am J Obstet Gynecol; 2021 Apr; 224(4):408-410. PubMed ID: 33385345
[No Abstract] [Full Text] [Related]
54. Phase II study of medroxyprogesterone acetate plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer.
Mitsuhashi A; Sato Y; Kiyokawa T; Koshizaka M; Hanaoka H; Shozu M
Ann Oncol; 2016 Feb; 27(2):262-6. PubMed ID: 26578736
[TBL] [Abstract][Full Text] [Related]
55. [Conservative treatments for endometrial cancer].
Eid M; Gonthier C; Bucau M; Koskas M
Rev Prat; 2022 Sep; 72(7):747-749. PubMed ID: 36511962
[TBL] [Abstract][Full Text] [Related]
56. Hysteroscopy and weight loss in treatment of endometrial cancer: case report and literature review.
Gallo A; D'alisa R; Di Spiezio Sardo A; Guerra S; Berardi G; Vitale SG; Palumbo M; Cretella P; Angioni S; Bifulco G; Musella M
Minim Invasive Ther Allied Technol; 2024 Apr; 33(2):109-119. PubMed ID: 38108527
[TBL] [Abstract][Full Text] [Related]
57. The role of hysteroscopy in fertility preservation in endometrial cancer and atypical endometrial hyperplasia: a semi-systematic literature review.
Bilir E; Kahramanoğlu İ
Arch Gynecol Obstet; 2023 Oct; 308(4):1113-1126. PubMed ID: 36807742
[TBL] [Abstract][Full Text] [Related]
58. Conservatively treated endometrial intraepithelial neoplasia/cancer: Risk of intrauterine synechiae.
Cordeiro Mitchell CN; Hunkler KF; Maher JY; Garbose RA; Gornet ME; Whiting-Collins LJ; Christianson MS
J Gynecol Obstet Hum Reprod; 2021 May; 50(5):101930. PubMed ID: 33022448
[TBL] [Abstract][Full Text] [Related]
59. Continued medical treatment for persistent early endometrial cancer in young women.
Cho A; Lee SW; Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT
Gynecol Oncol; 2021 Feb; 160(2):413-417. PubMed ID: 33246662
[TBL] [Abstract][Full Text] [Related]
60. A systematic review and meta-analysis of prognostic factors for remission in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma.
Guillon S; Popescu N; Phelippeau J; Koskas M
Int J Gynaecol Obstet; 2019 Sep; 146(3):277-288. PubMed ID: 31197826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
